Approval · Notice of Compliance 10801 · 2009
E-SE INJECTABLE: Notice of Compliance 10801
Issued November 24, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10801
- Date
- November 24, 2009
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in ownership
- Therapeutic class
- Selenium-Vitamin E supplement
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| E-SE INJECTABLE | 00518662 | Marketed |
Medicinal ingredients
- SODIUM SELENITE 2.5 MG per ML
- D-ALPHA TOCOPHERYL ACETATE 68 UNIT per ML